The Chicago White Sox have solidified their pitching staff for the 2024 season by agreeing to a new deal with Mike Clevinger. The contract, which hinges on the completion of a physical examination, showcases a base salary of $3 million with the potential for Clevinger to earn an additional $3 million through performance-based incentives. This commitment by the White Sox underscores their belief in Clevinger's abilities and potential contributions to the team's success in the upcoming season.
Reflecting on Clevinger's Professional Journey
Clevinger, whose career journey has been both eclectic and eventful, became a part of the White Sox under a one-year contract last winter, valued at $12 million. This move came at a time when Clevinger was embroiled in controversy, facing investigations over allegations of domestic violence. Despite these off-field challenges, Clevinger was not formally disciplined, allowing him to continue his professional pursuits.
On the pitcher's mound, Clevinger contributed significantly to the White Sox in the previous season, covering 131 1/3 innings and achieving a respectable 3.77 ERA. However, this performance did not come without its hurdles; Clevinger was placed on the injured list twice during the season, raising concerns about his durability. Notably, Clevinger underwent Tommy John surgery in November 2020—an event that added complexity to his career but from which he has since made a substantial recovery.
Analyzing his overall performance, Clevinger posted a 20% strikeout rate last season, a figure that falls below the league's average. This aspect of his game, coupled with a .281 batting average on balls in play and a 77.2% strand rate, hints at some measure of luck in his performance. Advanced metrics, such as a Fielding Independent Pitching (FIP) of 4.28 and a Skill-Interactive ERA (SIERA) of 4.81, further suggest that Clevinger's struggles might have been more pronounced than his ERA indicates.
Looking Toward 2024: What to Expect
As the White Sox gear up for the 2024 season, significant changes to their pitching lineup are underway, with Clevinger anticipated to play a pivotal role in the rotation. Given his past injuries and the intensive process of regaining form post-Tommy John surgery, it is plausible that Clevinger may require additional time to return to his peak condition. Consequently, the White Sox may also consider trading some of their current starting pitchers to optimize their roster.
Despite the challenges ahead, there is optimism surrounding Clevinger’s contributions to the team. A key focus for him in the coming season will be refining his pitch mechanics and boosting his strikeout rate—two areas that could significantly enhance his effectiveness on the mound.
The decision to re-sign Clevinger is indicative of the White Sox's confidence in his abilities and potential for growth. It represents a mutual belief that, with the right adjustments and focus, Clevinger can not only overcome the previous season's setbacks but also emerge as a formidable force in the team's pitching arsenal.
In summary, the White Sox's move to secure Mike Clevinger for the 2024 season is a testament to their strategic approach to building a competitive team. While Clevinger's recent journey through professional baseball has been marred by challenges both on and off the field, the White Sox envision a future where he plays an integral role in their pursuit of success. As Clevinger sets his sights on the upcoming season, his performance and contributions will undoubtedly be pivotal to the team's overall dynamic and success in the competitive landscape of Major League Baseball.
